TDB Funds 16-Valent Pneumococcal Vaccine Project
The Technology Development Board (TDB) under the Department of Science & Technology has approved financial assistance to TechInvention Lifecare Ltd., Navi Mumbai for establishing a commercial-scale cGMP facility to manufacture an indigenously developed 16-valent Pneumococcal Conjugate Vaccine (PCV-16). The initiative aims to strengthen India’s capacity in next-generation conjugate vaccines and reduce long-term dependency on imported … Continue reading TDB Funds 16-Valent Pneumococcal Vaccine Project
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed